Cargando…
Enhanced Neutralization Potency of Botulinum Neurotoxin Antibodies Using a Red Blood Cell-Targeting Fusion Protein
Botulinum neurotoxin (BoNT) potently inhibits cholinergic signaling at the neuromuscular junction. The ideal countermeasures for BoNT exposure are monoclonal antibodies or BoNT antisera, which form BoNT-containing immune complexes that are rapidly cleared from the general circulation. Clearance of o...
Autores principales: | Adekar, Sharad P., Segan, Andrew T., Chen, Cindy, Bermudez, Rodney, Elias, M. D., Selling, Bernard H., Kapadnis, B. P., Simpson, Lance L., Simon, Paul M., Dessain, Scott K. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047547/ https://www.ncbi.nlm.nih.gov/pubmed/21399689 http://dx.doi.org/10.1371/journal.pone.0017491 |
Ejemplares similares
-
Neutralization of Botulinum Neurotoxin by a Human Monoclonal Antibody Specific for the Catalytic Light Chain
por: Adekar, Sharad P., et al.
Publicado: (2008) -
New Modified Recombinant Botulinum Neurotoxin Type F with Enhanced Potency
por: Burgin, David, et al.
Publicado: (2021) -
RBC Adherence of Immune Complexes Containing Botulinum Toxin Improves Neutralization and Macrophage Uptake
por: Al-Saleem, Fetweh H., et al.
Publicado: (2017) -
Botulinum Neurotoxin Serotype a Specific Cell-Based Potency Assay to Replace the Mouse Bioassay
por: Fernández-Salas, Ester, et al.
Publicado: (2012) -
Neutralization of Botulinum Neurotoxin Type E by a Humanized Antibody
por: Derman, Yağmur, et al.
Publicado: (2016)